Share Market Update
The Australian share market has finished the 2018 financial year with a capital gain of 8.26% (before dividends), or up 13.8% including dividends.
The strong performance can be attributed to earnings upgrades from the resources sector and a strong performance from the high-growth market darlings including CSL, Macquarie & Aristocrat.
CSL, which has broken the $200 share price level in the last few days, has been one of the bigges...
Superannuation Contribution Caps
There are limits to the amount you can contribute into superannuation per year. These caps for the 2018 financial year are:
Non-Concessional Contribution Cap - $100,000
Concessional Contribution Cap - $25,000 for all ages
Non-concessional contributions are after-tax contributions including spouse contributions and contributions made under the Super Co-Contribution Scheme. Non-concessional contributions were prev...
On Tuesday, 8 May 2018, Treasurer Scott Morrison handed down the 2018-19 Federal Budget, his 3rd Budget.
In what is widely perceived to be an election Budget (and certainly the last full Budget before the next Federal election), in his Budget speech, the Treasurer said that, in 2017-18, the Budget deficit will be $18.2 billion, less than half what it was 2 years ago. The deficit will fall again to $14.5 billion in 2018-19, Mr Morrison said. Acco...
Share Market Update
The ASX200 has started 2018 with a negative quarter declining from 6,065.30 at 31 December 2017 to 5,759.40 at 31 March 2018, which represents a drop of 305.9 points or -5.04%.
This is the worst performance for a quarter since the GFC. Investors have only suffered two worse March quarters over the past 25 years – a 15% plunge in 2008 and a 6.3% loss in 1994.
This effectively neutralised the previous strong October to December 2017 qu...
Spotlight on CSL
Many of our clients will already be familiar with CSL. CSL is a global healthcare company and it’s a stock that has been included in the majority of our portfolios over the past few years. CSL’s core focus is on rare and serious diseases and influenza vaccines.
CSL Company History
CSL formerly known as The Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war. Over t...
Level One Financial Planning Pty Ltd. AFSL 280061. The information contained on this website is general information only. You agree that your access to, and use of, this site is subject to these terms and all applicable laws, and is at your own risk. This site and its contents are provided to you on an “as is” basis, the site may contain errors, faults and inaccuracies and may not be complete and current. It does not constitute personal financial or taxation advice. When making an investment decision you need to consider whether this information is appropriate to your financial situation, objectives and needs.